Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Substance Melatonin (Exclusively In The Potency 2 Mg), Atc N05Ch01 For The Period August 1St, 2023 - July 31St, 2025

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 67747874

  Document Type - Tender Notices

Description - § 130a paragraph 8 SGB V enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be supplied at the expense of the statutory health insurance companies. With regard to the releva nt legal regulations for the award of public contracts, a regular process of active ingredient-related, formal award procedures takes place according to the regulations of the 4th part of the GWB by the DAK-Gesundheit. For pharmaceuticals to be specified by the bidder in Annex 2 to the contract for the above-mentioned active ingredient melatonin (exclusively with a strength of 2 mg), ATC N05CH01, DAK-Gesundheit intends to conclude drug discount c

Gt Ref Id - 67747874

Deadline - Jun 05, 2025